EYLEA Trademark

Trademark Overview

On Monday, June 30, 2008, a trademark application was filed for EYLEA with the United States Patent and Trademark Office. The USPTO has given the EYLEA trademark a serial number of 77510978. The federal status of this trademark filing is REGISTERED AND RENEWED as of Saturday, April 23, 2022. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The EYLEA trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations, namely, ophthalmic; pharmaceuticals preparations for the treatment of ophthalmic diseases and conditions
eylea

General Information

Serial Number77510978
Word MarkEYLEA
Filing DateMonday, June 30, 2008
Status800 - REGISTERED AND RENEWED
Status DateSaturday, April 23, 2022
Registration Number4088223
Registration DateTuesday, January 17, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 2, 2008

Trademark Statements

Certificate of Correction for RegistrationIn the statement, line 4, "opthalmics" should be deleted, and "ophthalmic" should be inserted.
Goods and Servicespharmaceutical preparations, namely, ophthalmic; pharmaceuticals preparations for the treatment of ophthalmic diseases and conditions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 3, 2008
Primary Code005
First Use Anywhere DateMonday, November 21, 2011
First Use In Commerce DateMonday, November 21, 2011

Trademark Owner History

Party NameRegeneron Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591
Party NameRegeneron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591
Party NameRegeneron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Trademark Events

Event DateEvent Description
Thursday, July 14, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 14, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 14, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, April 24, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Saturday, April 23, 2022REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Saturday, April 23, 2022REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, April 22, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, December 23, 2021TEAS SECTION 8 & 9 RECEIVED
Sunday, January 17, 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Sunday, January 7, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sunday, January 7, 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, January 5, 2018TEAS SECTION 8 & 15 RECEIVED
Tuesday, January 17, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, January 6, 2015APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 6, 2015TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, February 1, 2012CORRECTION UNDER SECTION 7 ¿ PROCESSED
Tuesday, January 31, 2012CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, January 17, 2012REGISTERED-PRINCIPAL REGISTER
Saturday, December 10, 2011NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, December 9, 2011LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, December 6, 2011ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, December 6, 2011STATEMENT OF USE PROCESSING COMPLETE
Wednesday, November 23, 2011USE AMENDMENT FILED
Wednesday, November 23, 2011TEAS STATEMENT OF USE RECEIVED
Wednesday, November 23, 2011TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, August 2, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 1, 2011SOU EXTENSION 5 GRANTED
Tuesday, July 19, 2011SOU EXTENSION 5 FILED
Tuesday, July 19, 2011TEAS EXTENSION RECEIVED
Friday, January 7, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 6, 2011SOU EXTENSION 4 GRANTED
Thursday, December 16, 2010SOU EXTENSION 4 FILED
Thursday, December 16, 2010TEAS EXTENSION RECEIVED
Tuesday, June 8, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 7, 2010SOU EXTENSION 3 GRANTED
Friday, June 4, 2010SOU EXTENSION 3 FILED
Friday, June 4, 2010TEAS EXTENSION RECEIVED
Monday, January 25, 2010SOU EXTENSION 2 GRANTED
Friday, December 11, 2009SOU EXTENSION 2 FILED
Monday, January 25, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, December 11, 2009TEAS EXTENSION RECEIVED
Thursday, July 9, 2009SOU EXTENSION 1 GRANTED
Thursday, July 9, 2009SOU EXTENSION 1 FILED
Thursday, July 9, 2009TEAS EXTENSION RECEIVED
Tuesday, February 24, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 2, 2008PUBLISHED FOR OPPOSITION
Wednesday, November 12, 2008NOTICE OF PUBLICATION
Saturday, October 25, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, October 23, 2008ASSIGNED TO LIE
Sunday, October 12, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 3, 2008ASSIGNED TO EXAMINER
Thursday, July 3, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

eylea preparations ophthalmic diseases conditions treatment pharmaceuticals pharmaceutical namely